CN116199759A - Phoebe bournei PbMYB201 gene, coded protein and application thereof - Google Patents
Phoebe bournei PbMYB201 gene, coded protein and application thereof Download PDFInfo
- Publication number
- CN116199759A CN116199759A CN202310200866.6A CN202310200866A CN116199759A CN 116199759 A CN116199759 A CN 116199759A CN 202310200866 A CN202310200866 A CN 202310200866A CN 116199759 A CN116199759 A CN 116199759A
- Authority
- CN
- China
- Prior art keywords
- gene
- pbmyb201
- anthocyanin
- arabidopsis thaliana
- plant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 51
- 241001096797 Phoebe bournei Species 0.000 title claims abstract description 23
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 15
- 239000004410 anthocyanin Substances 0.000 claims abstract description 55
- 235000010208 anthocyanin Nutrition 0.000 claims abstract description 54
- 229930002877 anthocyanin Natural products 0.000 claims abstract description 54
- 150000004636 anthocyanins Chemical class 0.000 claims abstract description 54
- 241000196324 Embryophyta Species 0.000 claims abstract description 34
- 238000000034 method Methods 0.000 claims abstract description 28
- 230000001404 mediated effect Effects 0.000 claims abstract description 5
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 2
- 230000009261 transgenic effect Effects 0.000 claims description 17
- 238000009825 accumulation Methods 0.000 claims description 11
- 239000013598 vector Substances 0.000 claims description 10
- 241000589158 Agrobacterium Species 0.000 claims description 7
- 238000012216 screening Methods 0.000 claims description 6
- 150000001413 amino acids Chemical class 0.000 claims description 5
- 241000894006 Bacteria Species 0.000 claims description 2
- 230000000694 effects Effects 0.000 claims description 2
- 238000012546 transfer Methods 0.000 claims description 2
- 241000219195 Arabidopsis thaliana Species 0.000 abstract description 39
- 241000219194 Arabidopsis Species 0.000 abstract description 19
- 230000002018 overexpression Effects 0.000 abstract description 12
- 230000014509 gene expression Effects 0.000 abstract description 10
- 238000001514 detection method Methods 0.000 abstract description 9
- 239000002299 complementary DNA Substances 0.000 abstract description 6
- 238000000605 extraction Methods 0.000 abstract description 4
- 230000001131 transforming effect Effects 0.000 abstract description 4
- 108700026220 vif Genes Proteins 0.000 abstract description 4
- 241000589155 Agrobacterium tumefaciens Species 0.000 abstract description 2
- 238000010195 expression analysis Methods 0.000 abstract description 2
- 239000007788 liquid Substances 0.000 description 28
- 238000006243 chemical reaction Methods 0.000 description 15
- 239000000203 mixture Substances 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- 230000001580 bacterial effect Effects 0.000 description 14
- 239000002609 medium Substances 0.000 description 9
- 239000013612 plasmid Substances 0.000 description 9
- 239000006228 supernatant Substances 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 239000012634 fragment Substances 0.000 description 8
- 238000001179 sorption measurement Methods 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 7
- 230000001351 cycling effect Effects 0.000 description 7
- 239000000499 gel Substances 0.000 description 7
- 239000006166 lysate Substances 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 238000010367 cloning Methods 0.000 description 6
- 239000013604 expression vector Substances 0.000 description 6
- 230000012010 growth Effects 0.000 description 6
- 238000003753 real-time PCR Methods 0.000 description 6
- 230000001105 regulatory effect Effects 0.000 description 6
- 239000002699 waste material Substances 0.000 description 6
- 108020004414 DNA Proteins 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 5
- 108700019146 Transgenes Proteins 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 238000012163 sequencing technique Methods 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- 239000011543 agarose gel Substances 0.000 description 4
- 238000000246 agarose gel electrophoresis Methods 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 238000012215 gene cloning Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- -1 peroxynitrite anion Chemical class 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 238000007400 DNA extraction Methods 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241001092035 Photinia Species 0.000 description 3
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 3
- 238000007664 blowing Methods 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 238000004043 dyeing Methods 0.000 description 3
- 238000000227 grinding Methods 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 240000000161 Lagerstroemia indica Species 0.000 description 2
- 241000207746 Nicotiana benthamiana Species 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 238000010806 PrimeScriptTM RT Reagent kit Methods 0.000 description 2
- 238000011529 RT qPCR Methods 0.000 description 2
- 108091023040 Transcription factor Proteins 0.000 description 2
- 102000040945 Transcription factor Human genes 0.000 description 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 101150010487 are gene Proteins 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- YTMNONATNXDQJF-UBNZBFALSA-N chrysanthemin Chemical compound [Cl-].O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC2=C(O)C=C(O)C=C2[O+]=C1C1=CC=C(O)C(O)=C1 YTMNONATNXDQJF-UBNZBFALSA-N 0.000 description 2
- 239000013599 cloning vector Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000003306 harvesting Methods 0.000 description 2
- 230000006801 homologous recombination Effects 0.000 description 2
- 238000002744 homologous recombination Methods 0.000 description 2
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000000770 proinflammatory effect Effects 0.000 description 2
- 239000007845 reactive nitrogen species Substances 0.000 description 2
- 239000003642 reactive oxygen metabolite Substances 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 2
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
- 101150098516 3.1 gene Proteins 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 101100438273 Arabidopsis thaliana CAN1 gene Proteins 0.000 description 1
- 108010027344 Basic Helix-Loop-Helix Transcription Factors Proteins 0.000 description 1
- 102000018720 Basic Helix-Loop-Helix Transcription Factors Human genes 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- 102100021943 C-C motif chemokine 2 Human genes 0.000 description 1
- 101710155857 C-C motif chemokine 2 Proteins 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 235000008375 Decussocarpus nagi Nutrition 0.000 description 1
- 101100396994 Drosophila melanogaster Inos gene Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 101001033249 Homo sapiens Interleukin-1 beta Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102100039065 Interleukin-1 beta Human genes 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- 102000004889 Interleukin-6 Human genes 0.000 description 1
- 235000000283 Lagerstroemia parviflora Nutrition 0.000 description 1
- 241000218195 Lauraceae Species 0.000 description 1
- 208000001145 Metabolic Syndrome Diseases 0.000 description 1
- 235000016357 Mirtillo rosso Nutrition 0.000 description 1
- 244000132436 Myrica rubra Species 0.000 description 1
- 235000014631 Myrica rubra Nutrition 0.000 description 1
- 102000018745 NF-KappaB Inhibitor alpha Human genes 0.000 description 1
- 108010052419 NF-KappaB Inhibitor alpha Proteins 0.000 description 1
- 240000000220 Panda oleosa Species 0.000 description 1
- 235000016496 Panda oleosa Nutrition 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 241000604739 Phoebe Species 0.000 description 1
- 241001092500 Photinia x fraseri Species 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 239000013614 RNA sample Substances 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 240000007651 Rubus glaucus Species 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000017606 Vaccinium vitis idaea Nutrition 0.000 description 1
- 244000077923 Vaccinium vitis idaea Species 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
- 230000036579 abiotic stress Effects 0.000 description 1
- 238000011481 absorbance measurement Methods 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000008499 blood brain barrier function Effects 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000005978 brain dysfunction Effects 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 101150034785 gamma gene Proteins 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 230000006882 induction of apoptosis Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229930013686 lignan Natural products 0.000 description 1
- 150000005692 lignans Chemical class 0.000 description 1
- 235000009408 lignans Nutrition 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 229920006008 lipopolysaccharide Polymers 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- UTUXWUNJVVWSMO-UHFFFAOYSA-M potassium chlorate hydrochloride Chemical compound Cl.[K+].[O-]Cl(=O)=O UTUXWUNJVVWSMO-UHFFFAOYSA-M 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 239000012487 rinsing solution Substances 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000009105 vegetative growth Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/825—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving pigment biosynthesis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Nutrition Science (AREA)
- Plant Pathology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention belongs to the field of plant molecular biology, and particularly relates to a phoebe bournei PbMYB201 gene, a coded protein and application thereof. The full length of cDNA sequence of the gene is shown as SEQ ID No.1, and the amino acid sequence of the coded protein is shown as SEQ ID No. 2. And transforming the arabidopsis through an agrobacterium tumefaciens mediated method to obtain an overexpression arabidopsis plant. The result shows that the stem and leaf of the PbMYB201 over-expressed Arabidopsis thaliana has obviously red color compared with the stem and leaf of the Arabidopsis thaliana of the control group. And molecular detection is carried out on the arabidopsis thaliana, anthocyanin extraction and PbMYB201 gene expression analysis are carried out on the arabidopsis thaliana with over-expressed genes, and the result shows that the anthocyanin content in the leaf of the control arabidopsis thaliana is obviously lower than that in the arabidopsis thaliana with over-expressed PbMYB 201.
Description
Technical Field
The invention belongs to the technical field of plant biology, and relates to a phoebe bournei PbMYB201 gene, a coded protein and application thereof.
Background
Phoebe bournei belongs to Lauraceae genus plant, is a natural rare broad-leaved tree species with Chinese character, is one of original plants of golden silk Phoebe, and has high ornamental value due to diversity of leaf colors and upright trunks. Minnan also has extremely high commercial value, its wood being used for the production of expensive buildings, furniture and sculptures due to its remarkable durability and beautiful texture, and its extract containing various active substances such as anthocyanins and lignans, etc.
It has been shown that anthocyanins not only provide plants with a rich variety of colors, but also reduce the damage of plants from insects, pathogens, ultraviolet (UV) radiation and abiotic stress. There is also evidence that anthocyanin extracted from plants is good for human health, has strong antioxidant and anticancer ability, protects nerves, reduces blood lipid and blood sugar, prevents various chronic diseases and is used for treating related diseases as an anticancer agent and an antioxidant.
The anticancer effect of anthocyanin has been widely studied by researchers, and anthocyanin plays an anticancer role by regulating carbohydrate, lipid and protein metabolism, inflammation, oxidative stress, apoptosis signaling pathway and the like of cells. For example, anthocyanin in grape prevents tumor necrosis factor alpha from inducing NF- κB to be activated by inhibiting IκBα phosphorylation, and resists invasion of human colon cancer cells in a metering dependent manner. The anthocyanin can scavenge Reactive Oxygen Species (ROS) and Reactive Nitrogen Species (RNS), such as superoxide anion (O) 2 - ) Peroxide Radical (RCOO), hydrogen peroxide, hydroxyl radical (OH) and peroxynitrite anion (ONOO) - ) Etc. For example, anthocyanin isolated from cowberry fruit has strong scavenging effect on superoxide anionThe ability of ions and peroxynitrite anions. The ingestion of 320mg anthocyanin per day by a human suffering from metabolic syndrome can significantly inhibit the expression of NF- κB pathway-related pro-inflammatory factor genes and enhance PPAR- γ gene expression in the human to reduce the risk of inflammation. procyanidin-3-O-glucoside extracted from raspberry can inhibit lipopolysaccharide from inducing the production of proinflammatory factors IL-6, TNF-alpha, IL-1B, MCP-1 and Inos of mouse bone marrow macrophages. Also, it has been shown that ingestion of anthocyanin can protect the central nervous system, and anthocyanin can cross the blood brain barrier to reach multiple functional areas of the brain, reduce risk of brain dysfunction, and prevent cerebral ischemia and neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. Anthocyanin extract also can reduce sugar content in serum and urine, and can prevent oxygen free radical generation and reduce lipid oxidation.
Anthocyanin is a common flavonoid compound, and the core of anthocyanin biosynthesis regulation is a transcription factor of R2R3-MYB protein, and the transcription factor can activate the expression of enzyme genes in an anthocyanin biosynthesis pathway. For example, from stage S1 to S2, expression levels of MYB are significantly down-regulated, potentially limiting the flavonoid-anthocyanin biosynthetic pathway, resulting in reduced anthocyanin accumulation in the leaves of crape myrtle (Lagerstroemia indica). In addition, mrWD40-1 interacts with MYB and bHLH to enhance anthocyanin accumulation in Myrica rubra. MYB transcription factors control the anthocyanin content in the lamina of Nicotiana benthamiana (N.benthamiana). The MYB transcription factors for regulating anthocyanin biosynthesis are the MYB transcription factors, but MYB transcription factors for regulating anthocyanin accumulation in phoebe bournei are not reported yet. The early stage of the method discovers abundant anthocyanin in the photinia fraseri leaves, which is possibly related to the PbMYB201 gene with high expression, the PbMYB201 gene is overexpressed in the arabidopsis for the first time, the biological function of the PbMYB201 gene in anthocyanin accumulation is verified, and gene resources are provided for regulating and controlling the anthocyanin content for people.
Disclosure of Invention
In order to solve the problems, the invention provides a phoebe bournei PbMYB201 gene, a coded protein and application thereof.
Firstly, the invention provides a phoebe bournei PbMYB201 protein, which is:
1) A protein consisting of the amino acids shown in SEQ ID No. 2; or (b)
2) A protein derived from 1) which has equivalent activity and is obtained by substituting, deleting or adding one or more amino acids in the amino acid sequence shown in SEQ ID No. 2.
The invention also provides a gene for encoding the phoebe bournei PbMYB201 protein.
Preferably, the sequence of the gene is shown as SEQ ID No. 1.
The invention also provides an over-expression vector containing the gene, a host cell and engineering bacteria.
The invention also provides application of the gene in improving plant anthocyanin accumulation.
In one embodiment of the invention, the gene is transferred into the genome of a plant and overexpressed in the transgenic plant to increase plant anthocyanin accumulation.
The invention also provides a method for improving anthocyanin accumulation of plants, which adopts an agrobacterium-mediated method to transform a vector containing the genes into a plant genome, and screens to obtain transgenic plants. Wherein the gene is overexpressed in the transgenic plant and a higher amount of anthocyanin is accumulated compared to control plants.
The invention clones the PbMYB201 gene of photinia Min, stably converts Arabidopsis thaliana by an agrobacterium tumefaciens mediated method to obtain the Arabidopsis thaliana with over-expressed gene, carries out molecular detection on the Arabidopsis thaliana, and carries out expression analysis on the PbMYB201 of the over-expressed Arabidopsis thaliana, and the result shows that the PbMYB201 is obviously and highly expressed in the transgenic Arabidopsis thaliana. Further extracting anthocyanin from control Arabidopsis thaliana and over-expressed Arabidopsis thaliana, and detecting the absolute content of anthocyanin by using an ultraviolet-visible spectrophotometer. The result shows that the anthocyanin content detected in the over-expression arabidopsis thaliana is obviously higher than that detected in the control arabidopsis thaliana, and the anthocyanin content is respectively 0.1286ng/g and 0.0239ng/g; in a word, the PbMYB201 gene of photinia Min is over-expressed in arabidopsis for the first time, so that anthocyanin with higher concentration is obtained, namely, artificial regulation and control of anthocyanin synthesis in plants is feasible, and the method has a wide application prospect and economic benefit.
Drawings
FIG. 1 shows total RNA of the root, stem and leaf of Phoebe bournei.
FIG. 2 shows PCR amplification of the Phoebe bournei PbMYB201 gene.
FIG. 3 shows PCR detection of the overexpression vector bacterial liquid of the Phoebe bournei PbMYB201 gene.
FIG. 4 is a comparison of transgenic Arabidopsis phenotypes with wild type Arabidopsis. A: transgenic arabidopsis thaliana; b: wild type Arabidopsis thaliana; and C, anthocyanin extracting solution of transgenic arabidopsis thaliana and wild arabidopsis thaliana.
FIG. 5 is a PCR identification of positive lines and analysis of PbMYB201 expression levels. A: identifying positive strains by PCR; b: the expression level of PbMYB201 was analyzed by fluorescent quantitative PCR.
Fig. 6 is an anthocyanin content analysis of PbMYB201 over-expressed strains.
Detailed Description
The experimental methods used in the following examples are conventional methods unless otherwise specified.
Materials, reagents and the like used in the examples described below are commercially available unless otherwise specified.
In order to make the objects, technical solutions and advantages of the present invention more apparent, the present invention will be described in further detail with reference to the accompanying drawings and specific embodiments. It should be understood that the specific embodiments described herein are for purposes of illustration only and are not intended to limit the scope of the invention.
1. Material
1.1 Experimental materials
Phoebe bournei material was taken from Qingyuan laboratory forest farm in Lishui, zhejiang province.
Arabidopsis thaliana was grown in an intelligent laboratory building Arabidopsis thaliana growth chamber from the university of Zhejiang agriculture and forestry using Columbia wild type (Col-0) under conditions of 25℃for 16h/d.
1.2 Experimental reagents and instruments
The high-fidelity DNA polymerase, various restriction enzymes, markers and DNA gel recovery kits are all purchased from Takara Bao bioengineering (Dalian) Co., ltd; plasmid extraction kit and E.coli competence were purchased from Beijing full gold biotechnology (TransGen Biotech) Co., ltd; the PCR instrument is an American PE9700 PCR instrument; the ultra clean bench was purchased from su-zhou honest clean purification technologies.
1.3 primer Synthesis and sequencing
Primer synthesis and sequencing were all done by Zhejiang have well-being biotechnology limited.
2 method
2.1 extraction of Phoebe bournei Total RNA
The M5 Plant RNeasy Complex Mini Kit is adopted to extract the total RNA of phoebe bournei, and the steps are as follows:
(1) 1ml of the lysate CLB was taken into a centrifuge tube (if the CLB had precipitated or precipitated, it was first redissolved in a water bath at 65 ℃) and 5% beta-mercaptoethanol (1 ml of CLB plus 50. Mu.l of beta-mercaptoethanol) was added to the lysate CLB. After being mixed reversely, the mixture is preheated in a water bath at 65 ℃;
(2) Taking about 0.1g of sample, putting the sample into a mortar precooled by liquid nitrogen, and grinding the liquid nitrogen into fine powder;
(3) Transfer 100-200mg of the fine powder into a pre-heated lysate CLB (with β -mercaptoethanol added) centrifuge tube. Immediately and vigorously vortex for 30-60 seconds or blow with a suction head to mix and crack evenly to obtain satisfactory homogenization results;
(4) Short-time putting back into 65 ℃ water bath (5-10 min), and occasionally reversing the middle for 1-2 times to help cracking;
(5) Centrifuging the lysate at 13,000rpm for 10 minutes, precipitating uncleaved fragments;
(6) Lysate supernatant (more supernatant can be taken without exceeding the capacity of the genomic DNA removal column, which can increase yield) is transferred to a new centrifuge tube. Absolute ethanol (0.5 vol) was added to half the volume of the supernatant, at which time precipitation was possible, but the extraction process was not affected, and immediately, the mixture was blown and homogenized without centrifugation.
(7) Step 3 of immediately connecting the operation steps;
(8) The mixture (less than 720. Mu.l each time, and possibly in two additions) was loaded into a genome clearance column and centrifuged at 13,000rpm for 2 minutes, and the waste liquid was discarded;
(9) Placing the genome DNA removal column in a clean 2ml centrifuge tube, adding 500 μl of lysate RLT Plus into the genome removal column, centrifuging at 13,000rpm for 30 seconds, collecting filtrate, accurately estimating the volume of the filtrate (usually about 450-500 μl, the lost volume should be subtracted during filtration) by using a micropipette, adding 0.5 times of absolute ethanol, immediately blowing and mixing, and not centrifuging;
(10) Immediately adding the mixture (less than 720. Mu.l each time, and possibly two times) to an adsorption column RA (the adsorption column is placed in a collecting tube), centrifuging at 13,000rpm for 2 minutes, and discarding the waste liquid;
(11) Adding 700 μl deproteinized solution RW1, standing at room temperature for 1min, centrifuging at 13,000rpm for 30 seconds, and discarding the waste liquid;
(12) Mu.l of rinse liquid RW (please check whether absolute ethanol has been added |) was added, centrifuged at 13,000rpm for 30 seconds and the waste liquid was discarded. 500 μl of rinse RW was added and repeated;
(13) Placing the adsorption column RA back into the empty collecting pipe, centrifuging at 13,000rpm for 2 minutes, and removing the rinsing liquid as much as possible;
(14) Taking out the adsorption column RA, placing into an RNase Free centrifuge tube, adding 30-50 μl of RNase-Free H2O (which can increase the yield by heating in water bath at 70deg.C in advance) at the middle part of the adsorption membrane according to the expected RNA yield, standing at room temperature for 1min, and centrifuging at 12,000rpm for 1min;
(15) If RNA yield is expected>30. Mu.g, 30-50. Mu.l RNase-Free H were added 2 O repeat step 9, combining the two washes, or repeat step one time with the first eluent added back to the column.
2.2 Synthesis of first strand of reverse transcribed cDNA
The synthesis of the first strand of reverse transcribed cDNA was performed by Phoebe bournei RNA (Total RNA) with reference to the instructions of PrimeScriptTM RT Reagent Kit (Perfect Real Time) (TaKaRa).
(1) The following mixture was prepared for genome removal reaction:
the reaction procedure is: 42 ℃ for 2min;4 ℃, hold.
(2) The reverse transcription reaction was carried out by preparing the following mixture:
the reaction procedure is: 37 ℃ for 15min;85 ℃,5sec;4 ℃, hold.
2.3 cloning of the target Gene
2.3.1 Gene cloning
Specific primers for PbMYB201 were designed (Table 1), and the amplification system and procedure are shown in Table 2.
Table 1 cloning primers for PbMYB201
TABLE 2 cloning System
The reaction procedure: cycling for 35 times at 98 ℃,30sec,52 ℃,5sec,72 ℃ for 1min; 72 ℃ for 1min;16 ℃, hold.
2.3.2 recovery of the target fragment
1% agarose gel was prepared, the PCR products were detected by agarose gel electrophoresis, and if the band was correctly referred to MiniBEST Agarose Gel DNA Extraction Kit (Takara, dalian) the target fragment was excised and recovered.
(1) Prepare sterilized 2mL centrifuge tube and weigh empty tube mass.
(2) The slab was cut under an ultraviolet lamp with a clean scalpel, the slab was cut and placed into a 2mL centrifuge tube, and the slab volume was calculated by weighing (1 mg = 1 μl as standard).
(3) And adding Buffer GM with the volume of 3 times of gel into the gel block, dissolving the gel block at room temperature, and intermittently vibrating and mixing.
(3) After the gel was completely dissolved, isopropanol was added at a final concentration of 20%.
(4) Adding the solution obtained in the previous step into Spin Column, placing on Collection Tube, centrifuging at 12000rpm for 1min, and discarding the waste liquid.
(5) Adding 700 mu L of rinsing solution Buffer WB (absolute ethyl alcohol is added) into the adsorption column, and discarding waste liquid at the room temperature of 12000rpm and 1min;
(6) Repeating the step (5).
(6) Air separation 12000rpm,1min.
(7) The adsorption column was placed in a sterilized 1.5mL centrifuge tube, 30. Mu.L of sterilized water (preheated to 65 ℃) was added to the adsorption film, the mixture was allowed to stand at room temperature for 1min, centrifuged at 12000rpm for 1min, and the collected solution was kept at-20 ℃.
2.3.3 ligation and transformation of fragments of interest
(1) And (3) connection: the pEASY blue Zero vector (Transgene,blunt Zero Cloning Kit) are ligated with the gene of interest, mixed with the following solutions, gently mixed, and centrifuged briefly. And (2) PCR:25℃for 30min.
(2) Conversion: 2. Mu.L of the above-mentioned ligation product was added after the competent E.coli of Trans T1 (Transgene, beijing) was melted in an ice bath, the ice bath was left for 30min, the tube was rapidly and smoothly transferred to the ice bath for 30s, 500. Mu.L of LB medium containing no antibiotics was added, and the tube was cultured at 200rpm in a shaker at 37℃for 1h. 2min at 4000rpm, removing part of the supernatant, reserving 100 mu L of bacterial liquid, blowing and mixing the bacterial liquid again, plating on a solid LB culture medium (containing 50mg/L Kana), and culturing for 12h at 37 ℃ in an inverted mode.
(3) And (3) bacterial inspection: a white single colony was picked up on the plate, and 500. Mu.L of liquid LB medium (containing 50mg/L Kana) was added thereto, followed by culturing at 200rpm in a shaker at 37℃for 3-5 hours. PCR detection was performed using 1. Mu.L of the bacterial liquid as a template, and the primers were gene cloning primers, and the system and procedure were as follows.
The reaction procedure is: 94 ℃ for 5min; cycling at 94 ℃,30sec,52 ℃,30sec,72 ℃ for 1min for 35 times; 72 ℃ for 5min;16 ℃, hold.
(4) And detecting bacterial liquid PCR products by agarose gel electrophoresis, and selecting positive clones to be sent to Zhejiang Jingkang biotechnology Co.
(5) And (3) after the snapge comparison and sequencing result is correct, extracting plasmids by using Transgene EasyPure Plasmid MiniPrep Kit, and constructing an overexpression vector of the PbMYB201 gene by using the obtained positive plasmids.
2.4 construction of the overexpression vector by homologous recombination
According toII One Step Cloning Kit the over-expression vector is constructed by homologous recombination.
(1) Firstly, adding a kit containing a pK2W7-eYGFPuv-3xFLAG linker sequence on the basis of a target gene specific primer, and preparing the following PCR system (20 mu L) by using the positive plasmid obtained in the previous step as a template:
the reaction procedure: cycling for 35 times at 98 ℃,30sec,54 ℃,5sec,72 ℃ for 1min; 72 ℃ for 5min;16 ℃, hold.
(2) After ensuring that the product is a single band, the target fragment is subjected to gel cutting recovery by referring to MiniBEST Agarose Gel DNA Extraction Kit (Takara, dalian) instruction book.
(3) The overexpression vector pK2W 7-eYGFPv-3 xFLAG was subjected to double-enzyme tangentially, and the following PCR system was prepared using the plasmid pK2W 7-eYGFPv-3 xFLAG as a template:
the reaction procedure: 37 ℃ for 2h;16 ℃, hold.
(4) The desired fragment was subjected to gel cutting recovery by reference to MiniBEST Agarose Gel DNA Extraction Kit (Takara, dalian) instructions.
(5) The genetic transformation over-expression vector is selected from pK2W 7-eYGFPv-3 xFLAG, and constructs the over-expression vector of the PbMYB201 gene. The following mixed solutions were prepared at 25℃overnight.
Optimal cloning vector usage= [0.02×cloning vector base pair number ] ng (0.03 pmol) optimal insert usage= [0.04×insert base pair number ] ng (0.06 pmol)
The reaction procedure: 37 ℃ for 30min; cooling to 4 ℃ or immediately cooling on ice.
(2) 2. Mu.L of the strain is used for transforming Trans T1 (Transgene, beijing) escherichia coli competence, then a monoclonal strain is selected for bacterial liquid PCR detection, and the primers are gene cloning primers, wherein a PCR system is as follows:
the reaction procedure is: 94 ℃ for 5min; cycling at 94 ℃,30sec,52 ℃,30sec,72 ℃ for 1min for 35 times; 72 ℃ for 5min;16 ℃, hold.
(3) And detecting PCR products by agarose gel electrophoresis, transforming into Trans T1 (Transgene, beijing) escherichia coli competence, and selecting positive clones to be sent to Zhejiang Kakon biotechnology Co. Extracting the strain plasmid with correct sequencing result for later use.
2.5 conversion of Agrobacterium by liquid nitrogen method
(1) Taking out Agrobacterium GV1301 (a unique organism) stored at-80deg.C, and thawing on ice;
(2) Adding 0.5 mug of expression vector plasmid into the competence of agrobacterium, flicking and uniformly mixing, and respectively and sequentially placing the mixture on ice, in liquid nitrogen, in a water bath at 37 ℃ and in an ice-water mixture for 5min;
(3) Adding 700 mu L of fresh LB liquid medium without any resistance into a centrifuge tube, and placing the bacterial liquid into a shaking table (28 ℃ C., 200 rpm) for shake culture for 4-6h;
(4) Centrifuging (6000 rpm,2 min), pouring out part of the supernatant to make the volume of the residual liquid in the tube about 70-100 mu L, and blowing uniformly;
(5) Uniformly coating bacterial liquid on LB solid medium containing antibiotics (50 mg/L Kana and 50mg/L Rif), and inversely culturing in a biochemical incubator at 28 ℃ for 48-72 hours;
(6) And (3) selecting a monoclonal on the plate for bacterial liquid PCR detection, wherein primers are gene cloning primers, and a PCR system is as follows:
the reaction procedure is: 94 ℃ for 5min; cycling at 94 ℃,30sec,46 ℃,30sec,72 ℃,20sec, 30 times; 72 ℃ for 5min;16 ℃, hold.
(7) Adding 50% glycerol with the same volume into the monoclonal bacterial liquid with positive detection result, and storing in a refrigerator at-80 ℃.
2.6 Agrobacterium-mediated transformation of Arabidopsis thaliana
2.6.1 inflorescence dip-dyeing method for transforming Arabidopsis thaliana
(1) Wild type Arabidopsis seeds (COL-0) were sown on 1/2MS medium, vernalized for two days at 4℃and cultured in Arabidopsis growth chamber. And when four cotyledons grow, the cotyledons are moved into a soil seedling raising basin, and are continuously placed into a growth chamber for cultivation. About 3 weeks minus the main stem of arabidopsis thaliana, inhibiting apical dominance and promoting vegetative growth. After the arabidopsis is extracted out of a plurality of side branches and enters a full bloom stage, the existing fruit pods are cut off by scissors and the soil is thoroughly irrigated by water the day before the arabidopsis is infected, and then the inflorescence dip-dyeing method is adopted to infect the arabidopsis.
(2) Taking positive clone bacterial liquid according to the following formula 1:30 (Kana at 50mg/L and Rif at 50 mg/L) were added and shake-cultured overnight in a shaker (28 ℃ C., 200 rpm).
(3) 200 mu L of the bacterial liquid in the last step is added with 200mL of fresh LB resistant medium (50 mg/L Kana and 50mg/L Rif), and shake-cultured in a shaking table (28 ℃ C., 200 rpm) until the OD value reaches 0.8-1.0.
(4) Pouring bacterial liquid into a special container for dyeing, adding 5% of sucrose and 0.02% of surfactant Silwet-77, shaking and mixing uniformly;
(5) Soaking inflorescences of Col-0 into the dye liquor for 50s, and sucking redundant infection liquor on the surface of Arabidopsis thaliana by using a paper towel in a light press manner;
(6) Placing Arabidopsis thaliana into a seedling raising basin, and placing the Arabidopsis thaliana into an Arabidopsis thaliana growth chamber for dark culture for 2d;
(7) Placing Arabidopsis thaliana under light for normal growth, and collecting T0 generation seeds after the Arabidopsis thaliana is pod-grown Huang Liekai;
(8) Taking a proper amount of transgenic arabidopsis T0 seeds to be screened, adding the transgenic arabidopsis T0 seeds into a 1.5mL centrifuge tube, sequentially adding 75% ethanol, oscillating for 10min, and oscillating for 10min with absolute ethanol for sterilization.
(9) The seeds are poured into sterilized filter paper on an ultra-clean workbench to be dried, then the seeds are sown in a screening culture medium (1/2MS+50 mg/L Kana), vernalized for two days at 4 ℃ and placed in a growth chamber for culture.
(10) After about one week, T1-generation Arabidopsis thaliana with true leaves grown thereon was transferred to a medium, and after 2d of culture with a transparent cover for moisture preservation, the medium was cultured normally. And harvesting seeds after the arabidopsis is mature, and independently harvesting the arabidopsis by a single plant, and marking the arabidopsis as different numbers.
(11) And continuing to screen until a T3 generation homozygous strain is obtained according to a T0 generation seed screening method.
2.6.2 screening of transgenic Positive strains of Arabidopsis thaliana
DNA detection was performed on plants grown with true leaves in the screening medium using polymeric Mei super light speed mix MF848-01 (Mei 5bio, beijing) as follows:
(1) The yellow gun head is burned and melted by fire in advance to be self-made grinding pestle for standby.
(2) 1-2mm2 Arabidopsis thaliana leaves were placed in a 0.2 mM PCR tube, 20. Mu.L of lysate was added, and the wall was broken by rotary extrusion with a grinding pestle.
(3) The PCR tube is placed in a PCR instrument at 98 ℃ for 3-5min, and vortex vibration is carried out fully.
(4) Centrifuging at 12000rpm for 1-2min, taking 1 μl of supernatant as DNA template for PCR detection, wherein the system is as follows:
the reaction procedure is: 95 ℃ for 3min; cycling for 35 times at 94 ℃,25sec,52 ℃,25sec,72 ℃ for 1min; 72 ℃ for 5min;16 ℃, hold.
2.6.3 fluorescent quantitative PCR identification
Total RNA was extracted from the selected Arabidopsis positive plants using M5 Plant RNeasy Complex Mini Kit, and cDNA was reverse transcribed using PrimeScriptTM RT Reagent Kit (Perfect Real Time) (TaKaRa, dalian, china).
Fluorescent quantitative PCR was performed using ChamQ SYBR qPCR Master Mix (Vazyme, nanjing, china) and 20. Mu.L of a system mixture was prepared using Bio-Rad CFX-96: 2X ChamQ SYBR qPCR Master Mix. Mu. L, primer-F0.4. Mu. L, primer-R0.4. Mu.L, 50X ROX Reference Dye 1.4. Mu. L, cDNA 1. Mu.L and ddH 2 O7.8 μl; the reaction procedure is: 95 ℃ for 30s; cycling for 40 times at 95 ℃ for 10s and 60 ℃ for 30s; 65℃for 5s and 95℃for 5min (dissolution profile is set according to the type of instrument). The primers used for the fluorescent quantitative PCR are shown in Table 3, and U6 was selected as the reference gene.
TABLE 3 fluorescent quantitative PCR primers
2.7 analysis of the content of transgenic plant anthocyanin
0.5 g of leaves and stems of Arabidopsis thaliana was chopped and put into 10ml of methanol (containing 1% HCL) extract, shaken well, covered with a cover against light, and sonicated for 1 hour. After centrifugation (5000 rpm,10 minutes), the supernatant was used for anthocyanin content determination. Then, 2ml of the supernatant was aspirated, and mixed with 8 ml of potassium chlorate-hydrochloric acid buffer (pH 1.0) and sodium acetate-glacial acetic acid buffer (pH 4.5), respectively, and the mixture was incubated in a dark room at 40℃for 30 minutes. The absorbance of the mixture supernatant was measured at 520 nm, the anthocyanin content was measured and the correction was measured at 700 nm using an ultraviolet visible spectrophotometer (Thermo Scientific co., ltd, USA). All absorbance measurements were performed at room temperature with distilled water as a blank.
Obtaining absorbance and calculating anthocyanin content according to a formula:
ΔA=(A 520 -A 700 )Ph4.5-(A 520 -A 700 )Ph1
anthocyanin content (mg. 100 g) -1 )=ΔA·M·DF·V·100/m·ε·L
M: molecular weight of cyanidin-3-glucoside 449.2 g.mol -1 ;
DF: a dilution factor; take 1ml to 10ml volumetric flask, df=10
V: total volume of the extracting solution, mL;
m: weight, g;
epsilon: extinction coefficient of cyanidin-3-glucoside, 26 900L mol -1 ·cm -1 ;
L: optical path, 1cm.
3. Experimental results
3.1 analysis of total RNA extraction from leaves of Phoebe bournei
Extracting total RNA of Phoebe bournei by M5 Plant RNeasy Complex Mini Kit (figure 1), and measuring OD260/280 ratio of the extracted RNA by an ultraviolet spectrophotometer to be 1.8-2.1, which shows that the total RNA has better purity; the agarose gel electrophoresis result shows that the 18s and 28s bands of the RNA sample are very clear, and the RNA can be deduced to be not degraded, so that the requirement of the next experiment is met.
3.2 cloning and vector construction of Phoebe bournei PbMYB201 sequence
PbMYB201 is amplified from Phoebe bournei cDNA by a high-fidelity enzyme PCR amplification method to obtain a 917bp fragment (figure 2), the amplified fragment is connected to an over-expression vector pK2W 7-eYGFPv-3 xFLAG to transform escherichia coli, a single clone is selected to obtain positive clone (figure 3) through PCR verification, sequencing is carried out through Zhejiang Katsuzkya Co., ltd, the sequence is completely correct, one clone is selected to extract plasmid, agrobacterium is transformed, and arabidopsis thaliana is transformed.
3.3 screening of transgenic Positive strains of Arabidopsis thaliana
And (3) carrying out PCR identification on the T1 generation after the PbMYB201 of the photinia Min is converted into the Arabidopsis thaliana to obtain a positive strain (figure 4A), obtaining a T3 generation homozygous strain, detecting the PbMYB201 expression level (figure 4B) in each strain by using quantitative PCR, and selecting two strains OE2 and OE3 with higher expression to carry out subsequent analysis.
3.4 transgenic Arabidopsis thaliana flower phenotype
The phenotype of the T3 generation homozygous lines OE2 and OE3 (FIG. 5A) showed a pronounced reddening compared to Col (FIG. 5B). The anthocyanin extracts for OE2 and OE3 also differed significantly from Col (fig. 5C).
3.5 determination of the anthocyanin content of transgenic Arabidopsis thaliana
The anthocyanin content measurement shows that the anthocyanin content in the control arabidopsis leaves is 0.0239ng/g, and the anthocyanin content in the over-expression strain leaves is 0.1286ng/g, which is obviously higher than that of the wild type (figure 6), and shows that the plant anthocyanin biosynthesis pathway structural gene is regulated by PbMYB201, so that the accumulation of the arabidopsis anthocyanin is promoted. In conclusion, the PbMYB201 gene of the phoebe bournei is over-expressed, so that the anthocyanin content of the arabidopsis thaliana can be remarkably improved.
The foregoing is merely a preferred embodiment of the present invention, and it should be noted that it will be apparent to those skilled in the art that several modifications and variations can be made without departing from the technical principle of the present invention, and these modifications and variations should also be regarded as the scope of the invention.
Claims (10)
1. Phoebe bournei PbMYB201 protein, which is:
1) A protein consisting of the amino acids shown in SEQ ID No. 2; or (b)
2) A protein derived from 1) which has equivalent activity and is obtained by substituting, deleting or adding one or more amino acids in the amino acid sequence shown in SEQ ID No. 2.
2. A gene encoding the phoebe bournei PbMYB201 protein of claim 1.
3. The gene of claim 2, wherein the sequence is set forth in SEQ ID No. 1.
4. A vector comprising the gene of claim 2 or 3.
5. A host cell comprising the vector of claim 4.
6. An engineered bacterium comprising the gene of claim 2 or 3.
7. Use of the gene of claim 2 or 3 for increasing plant accumulation of anthocyanin.
8. The use according to claim 7, wherein the gene is transferred into the genome of a plant and overexpressed in a transgenic plant to increase plant anthocyanin accumulation.
9. A method for improving anthocyanin accumulation in plants, which adopts an agrobacterium-mediated method to transfer a vector containing the gene of claim 2 or 3 into a plant genome, and screening to obtain transgenic plants.
10. The method of claim 9, wherein said gene is overexpressed in said transgenic plant and a higher level of anthocyanin is accumulated as compared to a control plant.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310200866.6A CN116199759A (en) | 2023-02-22 | 2023-02-22 | Phoebe bournei PbMYB201 gene, coded protein and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310200866.6A CN116199759A (en) | 2023-02-22 | 2023-02-22 | Phoebe bournei PbMYB201 gene, coded protein and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116199759A true CN116199759A (en) | 2023-06-02 |
Family
ID=86509252
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310200866.6A Pending CN116199759A (en) | 2023-02-22 | 2023-02-22 | Phoebe bournei PbMYB201 gene, coded protein and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116199759A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116732051A (en) * | 2023-07-17 | 2023-09-12 | 江西省科学院生物资源研究所 | Ganlong No.1 CcTT2_LIKE gene and expression protein and application thereof |
CN116814652A (en) * | 2023-07-17 | 2023-09-29 | 江西省科学院生物资源研究所 | Ganlong No.1 CcMYB4_LIKE gene and expression protein and application thereof |
CN116891856A (en) * | 2023-07-17 | 2023-10-17 | 江西省科学院生物资源研究所 | Ganlong No.1 CcMYB10_LIKE gene and expression protein and application thereof |
-
2023
- 2023-02-22 CN CN202310200866.6A patent/CN116199759A/en active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116732051A (en) * | 2023-07-17 | 2023-09-12 | 江西省科学院生物资源研究所 | Ganlong No.1 CcTT2_LIKE gene and expression protein and application thereof |
CN116814652A (en) * | 2023-07-17 | 2023-09-29 | 江西省科学院生物资源研究所 | Ganlong No.1 CcMYB4_LIKE gene and expression protein and application thereof |
CN116891856A (en) * | 2023-07-17 | 2023-10-17 | 江西省科学院生物资源研究所 | Ganlong No.1 CcMYB10_LIKE gene and expression protein and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN116199759A (en) | Phoebe bournei PbMYB201 gene, coded protein and application thereof | |
CN108841841B (en) | Cloning of tomato transcription factor SlbZIP6 and application thereof in high temperature stress resistance | |
US20210403940A1 (en) | Method and formulation for inducing abortion or deformation of plant seeds | |
CN109081865B (en) | Phyllostachys pubescens PeVQ28 protein and coding gene and application thereof | |
AU2020100800A4 (en) | Use of aegilops tauschii hmt1 gene | |
CN108047320A (en) | The application of Protein G mMYB12 and encoding gene in isoflavones accumulation and salt tolerance is improved | |
CN102321649A (en) | Lycium chinense miller lycopene beta-cyclase gene, recombinant vector containing gene, host cell and application | |
CN104694491B (en) | The anthocyanin reductase RrANR genes and its coding albumen of rose and application | |
CN107400671A (en) | Pear fruit saccharide transporter gene PbTMT4 and its application | |
CN105420221B (en) | Albumen and the application of wax met AMP ase gene C pCAF1 and its coding | |
CN114752607B (en) | Banana MtLUT5 gene, cloning method, expression vector and application | |
CN115197951B (en) | Tea tree flavonol synthesis candidate gene CsNAC086 and application thereof | |
CN115058433B (en) | Tobacco leaf yellowing regulatory gene NtMYB2, protein and application thereof | |
CN112725375B (en) | Silencing vector and application thereof in transgenic plants | |
CN105585620B (en) | Soybean protein GmAIRP1 and its encoding gene are cultivating the application in resistance plant | |
CN108004267A (en) | A kind of new method for extending tamato fruit shelf life using technique for gene engineering | |
CN116023459A (en) | Phoebe Minnanensis PbHLH 30 gene, coded protein and application thereof | |
CN113337522A (en) | Application of cotton GhNFYC4 gene in promoting plant flowering | |
CN106701776B (en) | Gene causing internal heat of human body by Rutaceae plant and application thereof | |
CN114875044B (en) | Wild grape VyVTE gene, protein coded by same and application thereof | |
CN117384914B (en) | MhEML4 gene clone and application thereof in seed abortion | |
CN116855535B (en) | Application of ZjCML gene in improving cold resistance of wild jujube callus | |
CN112391403B (en) | Application of TGW10 gene in improvement of crop grain type traits | |
CN114941003B (en) | Wild grape vyMPBQ gene, protein coded by same and application thereof | |
CN114807166B (en) | Liriodendron transcription factor LcbHLH02399 gene and expression protein and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |